Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02010593 · ClinicalTrials.gov registry record · Phase 2
Safety and Pharmacokinetics of Dapivirine Vaginal Ring in Post-menopausal Women
A Phase 2 study, sponsored by International Partnership for Microbicides.
- Completed
- Registry status
- Phase 2
- Development phase
- 96
- Enrollment target
NCT02010593 is a Phase 2 study that has completed, run by International Partnership for Microbicides. The registered enrollment target is 96 participants.
The verdict
NCT02010593, a Phase 2 study, has completed, sponsored by International Partnership for Microbicides.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 96 participants
- Enrollment target
Study Summary
This study will evaluate the safety of the dapivirine vaginal ring when inserts once every 4 weeks in postmenopausal women over 12 weeks of product use.
Interventions
- DRUG Dapivirine Vaginal Ring
- DRUG Placebo Vaginal Ring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2013-12 |
| Est. Completion | 2015-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02010593
The ClinicalTrials.gov registry entry for NCT02010593 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is International Partnership for Microbicides, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dapivirine Vaginal Ring is the first listed.
NCT02010593 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02010593 about?
NCT02010593 is a clinical study titled "Safety and Pharmacokinetics of Dapivirine Vaginal Ring in Post-menopausal Women". This study will evaluate the safety of the dapivirine vaginal ring when inserts once every 4 weeks in postmenopausal women over 12 weeks of product use.
What is the current status of trial NCT02010593?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 96 participants. The study started on 2013-12. Estimated completion is 2015-04.
What interventions are being tested in trial NCT02010593?
The interventions under investigation include: Dapivirine Vaginal Ring (DRUG), Placebo Vaginal Ring (DRUG).
Who is sponsoring clinical trial NCT02010593?
This trial is sponsored by International Partnership for Microbicides, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.